Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12266 ◽

2013 ◽

Vol 37 (8) ◽

pp. 767-775 ◽

Author(s):

B. Flourié ◽

H. Hagège ◽

G. Tucat ◽

D. Maetz ◽

X. Hébuterne ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Randomised Clinical Trial ◽

Prolonged Release ◽

Active Ulcerative Colitis

Download Full-text

Randomised clinical trial: early assessment after 2weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question

Yearbook of Medicine ◽

10.1016/s0084-3873(11)00325-7 ◽

2011 ◽

Vol 2011 ◽

pp. 450-451

Author(s):

M.F. Picco

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Randomised Clinical Trial ◽

High Dose ◽

Active Ulcerative Colitis ◽

Early Assessment

Download Full-text

Faculty Opinions recommendation of Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.7569957.7866056 ◽

2011 ◽

Author(s):

Russell Cohen ◽

Laura Harrell

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Sustained Release ◽

Randomised Clinical Trial ◽

Herbal Extract ◽

Active Ulcerative Colitis ◽

Double Blind ◽

Blind Comparison

Download Full-text

Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis

Biomedicine & Pharmacotherapy ◽

10.1016/j.biopha.2021.111580 ◽

2021 ◽

Vol 139 ◽

pp. 111580

Author(s):

Hong Shen ◽

Shengsheng Zhang ◽

Wenxia Zhao ◽

Shunping Ren ◽

Xiao Ke ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Randomised Clinical Trial ◽

Active Ulcerative Colitis ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Clinical Trial

Download Full-text

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04515.x ◽

2010 ◽

Vol 33 (2) ◽

pp. 194-202 ◽

Author(s):

T. Tang ◽

S. R. Targan ◽

Z.-S. Li ◽

C. Xu ◽

V. S. Byers ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Sustained Release ◽

Randomised Clinical Trial ◽

Herbal Extract ◽

Active Ulcerative Colitis ◽

Double Blind ◽

Blind Comparison

Download Full-text

Randomised clinical trial: early assessment after 2 weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2011.04620.x ◽

2011 ◽

Vol 33 (9) ◽

pp. 1028-1035 ◽

Author(s):

T. R. Orchard ◽

S. A. P. van der Geest ◽

S. P. L. Travis

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Randomised Clinical Trial ◽

High Dose ◽

Active Ulcerative Colitis ◽

Early Assessment

Download Full-text

Randomised clinical trial: early assessment after 2weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question

Yearbook of Gastroenterology ◽

10.1016/j.ygas.2011.07.114 ◽

2011 ◽

Vol 2011 ◽

pp. 176-177

Author(s):

M.F. Picco

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Randomised Clinical Trial ◽

High Dose ◽

Active Ulcerative Colitis ◽

Early Assessment

Download Full-text

Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.13653 ◽

2016 ◽

Vol 44 (2) ◽

pp. 157-169 ◽

Author(s):

W. J. Sandborn ◽

B. R. Bhandari ◽

R. Fogel ◽

J. Onken ◽

E. Yen ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Monoclonal Antibody ◽

Matrix Metalloproteinase ◽

Phase 1 ◽

Randomised Clinical Trial ◽

Matrix Metalloproteinase 9 ◽

Dose Ranging ◽

Metalloproteinase 9

Download Full-text

Efficacy and safety of prolonged-release hyaluronic acid derivative vaginal application in the postpartum period: a prospective randomised clinical trial

Annals of Medicine ◽

10.1080/07853890.2021.1974083 ◽

2021 ◽

Vol 53 (1) ◽

pp. 1589-1597

Author(s):

Claudio Gustavino ◽

Paolo Sala ◽

Nadia Cusini ◽

Brunella Gravina ◽

Cecilia Ronzini ◽

...

Keyword(s):

Clinical Trial ◽

Hyaluronic Acid ◽

Acid Derivative ◽

Postpartum Period ◽

Randomised Clinical Trial ◽

Prolonged Release ◽

Efficacy And Safety

Download Full-text

Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study

The American Journal of Gastroenterology ◽

10.1038/ajg.2015.114 ◽

2015 ◽

Vol 110 (5) ◽

pp. 708-715 ◽

Author(s):

Gert Van Assche ◽

Francesco Manguso ◽

Marco Zibellini ◽

José Luis Cabriada Nuño ◽

Adrian Goldis ◽

...

Keyword(s):

Ulcerative Colitis ◽

Beclomethasone Dipropionate ◽

Prolonged Release ◽

Active Ulcerative Colitis ◽

Double Blind ◽

Parallel Group Study ◽

Download Full-text

Olsalazine in the Treatment of Active Ulcerative Colitis: A Placebo Controlled Clinical Trial and Assessment of Drug Disposition

Scandinavian Journal of Gastroenterology ◽

10.3109/00365528809101552 ◽

1988 ◽

Vol 23 (sup148) ◽

pp. 61-69 ◽

Author(s):

D. J. Hetzel ◽

D. J. C. Shearman ◽

J. Labrooy ◽

F. Bochner ◽

D. M. Imhoff ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Drug Disposition ◽

Controlled Clinical Trial ◽

Active Ulcerative Colitis

Download Full-text